C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2007
08/30/2007	WO2007097633A1 A method for extracting enzymes from an enzyme-containing raw material and their use for preparing enzyme hydrolysate
08/30/2007	WO2007097461A1 Antibody for treatment of hepatitis c
08/30/2007	WO2007097418A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent
08/30/2007	WO2007097065A1 Hapten compound and antibody
08/30/2007	WO2007095749A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2
08/30/2007	WO2007095748A1 Cancerous disease modifying antibody 141205-05
08/30/2007	WO2007095747A1 Cytotoxicity mediation of cells evidencing surface expression of cd59
08/30/2007	WO2007095746A1 Cancerous disease modifying antibodies
08/30/2007	WO2007095745A1 Cancerous disease modifying antibody 141205-02
08/30/2007	WO2005121331A3 Truncated galnact2 polypeptides and nucleic acids
08/30/2007	WO2005062954A3 Modulation of hcn channels by second messengers
08/30/2007	WO2004009836A3 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use
08/30/2007	US20070204355 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein
08/30/2007	US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces
08/30/2007	US20070203075 Novel lactam ring-opening enzyme and use thereof
08/30/2007	US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties
08/30/2007	US20070203061 Adiponectin expression-inducing agents and uses thereof
08/30/2007	US20070202573 Soluble fusion proteins comprising heterologous polypeptides
08/30/2007	US20070202572 Microorganisms for therapy
08/30/2007	US20070202571 Method for microbial production of amino acids of the spartate and/or glutamate family and agents which can be used in said method
08/30/2007	US20070202570 Enzyme composition, low molecular weight hyaluronan and process for preparing the same
08/30/2007	US20070202569 Controlling formation of acidic sugar chain associated with heterologously expressed glycoproteins in pichia; preparing less antigenic polypeptides; pharmacology; drug design; gene participating in addition of mannose phosphate to a sugar chain in a core-like sugar chain of a glycoprotein is controlled
08/30/2007	US20070202568 Insertion of Furin Protease Cleavage Sites in Membrane Proteins and Uses Thereof
08/30/2007	US20070202567 Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep)
08/30/2007	US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them
08/30/2007	US20070202552 Binding Polypeptides and Uses Thereof
08/30/2007	US20070202551 TGFBeta
08/30/2007	US20070202550 Novel G protein-coupled receptor protein, its DNA and ligand thereof
08/30/2007	US20070202528 Methods for modulating proteins not previously known as proteases
08/30/2007	US20070202520 Novel lipase
08/30/2007	US20070202512 Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof
08/30/2007	US20070202508 Novel thermophilic proteins and the nucleic acids encoding them
08/30/2007	US20070202506 Single nucleotide polymorphisms predicting cardiovascular disease
08/30/2007	US20070202501 Proteins Expressed In Ink Cells
08/30/2007	US20070202500 Acylglycerol Acyltransferase-Like Protein Mgat-X2 And Uses Thereof
08/30/2007	US20070202132 Allergenic proteins and peptides from dog dander and uses therefor
08/30/2007	US20070202113 Cell surface glycoprotein specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents
08/30/2007	US20070202110 Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer
08/30/2007	US20070202108 Antithrombotic agents; monoclonal antibody that inhibits collagen-induced platelet aggregation at an IC50 of less than 7 mu g/ml
08/30/2007	US20070202107 Novel kinases
08/30/2007	US20070202105 Recombinant immunoglobulin specific to tumor necrosis factor for treatment and prevention of sepsis, infection and autoimmune diseases
08/30/2007	US20070202103 Compounds For Targeting
08/30/2007	US20070202097 Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof
08/30/2007	US20070202096 XAF genes and polypeptides: methods and reagents for modulating apoptosis
08/30/2007	US20070202093 Systems and Methods to Reduce Gel Retraction
08/30/2007	DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins
08/30/2007	CA2643603A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2
08/30/2007	CA2643561A1 Cancerous disease modifying antibody 141205-05
08/30/2007	CA2643555A1 Cytotoxicity mediation of cells evidencing surface expression of cd59
08/30/2007	CA2643144A1 Cancerous disease modifying antibody 141205-04
08/30/2007	CA2643063A1 Cancerous disease modifying antibody 141205-02
08/29/2007	EP1826218A1 Antihuman baff antibody
08/29/2007	EP1824998A1 Method for directing nucleic acids to plastids
08/29/2007	EP1824986A2 Biomaterial which can successively carry out a solution/gel transition then a gel/solution transition
08/29/2007	EP1824980A2 Rhamnose promoter expression system
08/29/2007	EP1824978A1 Hcv f protein and uses thereof
08/29/2007	EP1824875A1 Plant proteins having an abscisic acid binding site and methods of use
08/29/2007	EP1824796A2 Protein scaffolds and uses thereof
08/29/2007	EP1824510A2 Use of flagellin in the immunotherapy of yersinia pestis
08/29/2007	EP1517913B9 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
08/29/2007	EP1450847A4 Apo2 ligand/trail formulations
08/29/2007	EP1449913B1 Gamma-glutamylcysteine-producing yeast
08/29/2007	EP1414958B1 Method for gene expression
08/29/2007	EP1165781B1 Protease resistant flint analogs
08/29/2007	EP1140997B1 Chlamydia trachomatis antigens
08/29/2007	EP1054963B1 Sequences of an ih ionic channel and the use thereof
08/29/2007	EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/29/2007	EP0953644B1 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola
08/29/2007	EP0763059B1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
08/29/2007	EP0736605B2 Process for producing proteins
08/29/2007	CN101027412A Urine markers for detection of bladder cancer
08/29/2007	CN101027388A Modified human acid sphingomyelinase having increased activity, and methods for making the same
08/29/2007	CN101024831A A tumor necrosis factor related ligand
08/29/2007	CN100334226C Process and application for producing fermant protein peptide
08/29/2007	CN100334225C I-type protein small peptide and its preparing method
08/29/2007	CN100334216C Method and use of producing soluble recombinant protein in colibacillus
08/29/2007	CN100334214C Hybrid expression of Neisseria protein
08/29/2007	CN100334213C Genes of corynebacteria
08/29/2007	CN100334207C Process for preparing aspergillus flavus urate oxidase
08/29/2007	CN100334114C Novel fusion protein production and uses
08/28/2007	US7262289 KCNQ potassium channels and methods of modulating same
08/28/2007	US7262287 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same
08/28/2007	US7262283 Facilitates the isolation of proteins from the cell nucleus interior as an independent fraction by separating the complete proteome into partial proteomes and thus makes this fraction available for further analyses for the first time in adequate purity and quality
08/28/2007	US7262280 G-protein fusion receptors and constructs encoding same
08/28/2007	US7262278 Anti-HLA-DR antibody
08/28/2007	US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof
08/28/2007	US7262276 Two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv
08/28/2007	US7262274 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
08/28/2007	US7262272 Epitope from an alpha -helical surface region of a protein inserted into a coiled-coil polypeptide template; conformation-specific antibodies can be generated for use as therapeutic and diagnostic ligand.
08/28/2007	US7262271 Immunogens as well as antibodies
08/28/2007	US7262268 Acylating a destryptophan compound to obtain an ornithin amino protected compound, removing the ornithine protecting group; antibiotic daptomycin stereoisomeric compounds
08/28/2007	US7262267 Polypeptide mediating cell permeability
08/28/2007	US7262062 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics
08/28/2007	US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit
08/28/2007	US7262051 A bicistronic DNA construct containing IRES of enterovirus and an amount of amantadine that inhibits the IRES-dependent translation activity in a dose-dependent manner without interfering the CAP-dependent translation
08/28/2007	US7262050 Humanised antibodies
08/28/2007	US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/28/2007	US7262043 Polypeptide having a specific sequence that exhibits beta -secretase activity and lacks a transmembrane domainand polynucleotides encoding them; useful for identifying agents that inhibit secretase and are thus therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
08/28/2007	US7262042 Alkaline proteases of the subtilisin type
08/28/2007	US7262041 Expression of granular starch hydrolyzing enzyme in Trichoderma

1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 1125